blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1553075

EP1553075 - LPA RECEPTOR ANTAGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.06.2014
Database last updated on 22.08.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
ONO PHARMACEUTICAL CO., LTD.
1-5, Doshomachi 2-chome Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
[2013/33]
Former [2005/28]For all designated states
ONO PHARMACEUTICAL CO., LTD.
1-5, Doshomachi 2-chome, Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
Inventor(s)01 / TERAKADO, Masahiko@c/o Minase Research Institute
1-1, Sakurai 3-chome, Shimamoto-cho
Mishima-gun, Osaka 618-8585 / JP
02 / NAKADE, Shinji@c/o Minase Research Institute
1-1, Sakurai 3-chome, Shima-gun
Osaka 618-8585 / JP
03 / SEKO, Takuya@c/o Ono Pharmaceutical Co., Ltd.
1-5, Doshomachi 2-chome, Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
04 / TAKAOKA, Yoshikazu@c/o Minase Research Institute
1-1, Sakurai 3-chome Shimamoto-cho
Mishima-gun, Osaka 618-8585 / JP
 [2013/33]
Former [2005/28]01 / TERAKADO, Masahiko c/o Minase Research Institute
1-1, Sakurai 3-chome, Shimamoto-cho
Mishima-gun, Osaka 618-8585 / JP
02 / NAKADE, Shinji c/o Minase Research Institute
1-1, Sakurai 3-chome, Shima-gun
Osaka 618-8585 / JP
03 / SEKO, Takuya c/o Ono Pharmaceutical Co., Ltd.
1-5, Doshomachi 2-chome, Chuo-ku
Osaka-shi, Osaka 541-8526 / JP
04 / TAKAOKA, Yoshikazu c/o Minase Research Institute
1-1, Sakurai 3-chome Shimamoto-cho
Mishima-gun, Osaka 618-8585 / JP
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[N/P]
Former [2013/33]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Former [2011/23]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Leopoldstrasse 4
80802 München / DE
Former [2011/14]Goldbach, Klara, et al
Grünecker Kinkeldey Stockmair & Schwanhäusser Anwaltssozietät Leopoldstrasse 4
80802 München / DE
Former [2009/41]Schön, Christoph, et al
Kroher.Strobel Rechts- und Patentanwälte Bavariaring 20
80336 München / DE
Former [2005/28]Henkel, Feiler & Hänzel
Möhlstrasse 37
81675 München / DE
Application number, filing date03733131.128.05.2003
[2005/28]
WO2003JP06680
Priority number, dateJP2002029113703.10.2002         Original published format: JP 2002291137
[2005/28]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004031118
Date:15.04.2004
Language:EN
[2004/16]
Type: A1 Application with search report 
No.:EP1553075
Date:13.07.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 15.04.2004 takes the place of the publication of the European patent application.
[2005/28]
Type: B1 Patent specification 
No.:EP1553075
Date:14.08.2013
Language:EN
[2013/33]
Search report(s)International search report - published on:JP15.04.2004
(Supplementary) European search report - dispatched on:EP06.10.2009
ClassificationIPC:C07C65/40, C07C235/52, A61K31/192, A61K31/216, A61K31/402, A61K31/4035, A61K31/404, A61K31/41, A61K31/4184, A61K31/4402, A61K31/445, A61K31/472, A61K31/517, A61K31/5415
[2005/28]
CPC:
C07D211/96 (EP,US); A61P1/16 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P13/00 (EP); A61P13/02 (EP);
A61P13/08 (EP); A61P13/10 (EP); A61P13/12 (EP);
A61P17/00 (EP); A61P17/06 (EP); A61P19/10 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P27/02 (EP);
A61P27/06 (EP); A61P29/00 (EP); A61P3/04 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P9/10 (EP); C07C217/58 (EP,US); C07C233/22 (EP,US);
C07C233/51 (EP,US); C07C233/63 (EP,US); C07C233/73 (EP,US);
C07C233/87 (EP,US); C07C235/34 (EP,US); C07C235/48 (EP,US);
C07C235/52 (EP,US); C07D207/12 (EP,US); C07D207/327 (EP,US);
C07D209/08 (EP,US); C07D209/12 (EP,US); C07D209/14 (EP,US);
C07D209/46 (EP,US); C07D213/65 (EP,US); C07D213/89 (EP,US);
C07D217/06 (EP,US); C07D231/12 (EP,US); C07D231/14 (EP,US);
C07D235/12 (EP,US); C07D239/91 (EP,US); C07D257/04 (EP,US);
C07D277/36 (EP,US); C07D277/56 (EP,US); C07D279/08 (EP,US);
C07D307/68 (EP,US); C07D317/68 (EP,US); C07D333/70 (EP,US);
C07C2601/08 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/28]
TitleGerman:LPA-REZEPTOR-ANTAGONISTEN[2005/28]
English:LPA RECEPTOR ANTAGONISTS[2005/28]
French:ANTAGONISTES DES RECEPTEURS DE L'ACIDE LYSOPHOSPHATIDIQUE (LPA)[2005/28]
Entry into regional phase01.04.2005Translation filed 
01.04.2005National basic fee paid 
01.04.2005Search fee paid 
01.04.2005Designation fee(s) paid 
01.04.2005Examination fee paid 
Examination procedure09.04.2004Request for preliminary examination filed
International Preliminary Examining Authority: JP
01.04.2005Examination requested  [2005/28]
22.11.2010Despatch of a communication from the examining division (Time limit: M04)
28.03.2011Reply to a communication from the examining division
22.03.2012Despatch of a communication from the examining division (Time limit: M04)
24.07.2012Reply to a communication from the examining division
27.02.2013Communication of intention to grant the patent
02.07.2013Fee for grant paid
02.07.2013Fee for publishing/printing paid
Divisional application(s)EP12007801.9  / EP2565178
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.11.2010
Opposition(s)15.05.2014No opposition filed within time limit [2014/30]
Fees paidRenewal fee
01.04.2005Renewal fee patent year 03
31.05.2006Renewal fee patent year 04
31.05.2007Renewal fee patent year 05
31.03.2008Renewal fee patent year 06
28.05.2009Renewal fee patent year 07
31.03.2010Renewal fee patent year 08
27.05.2011Renewal fee patent year 09
29.03.2012Renewal fee patent year 10
28.05.2013Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.05.2003
AT14.08.2013
BE14.08.2013
BG14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
ES14.08.2013
FI14.08.2013
IT14.08.2013
MC14.08.2013
NL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
TR14.08.2013
GR15.11.2013
PT16.12.2013
[2016/33]
Former [2016/32]HU28.05.2003
AT14.08.2013
BE14.08.2013
BG14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
ES14.08.2013
FI14.08.2013
IT14.08.2013
MC14.08.2013
NL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
GR15.11.2013
PT16.12.2013
Former [2016/25]AT14.08.2013
BE14.08.2013
BG14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
ES14.08.2013
FI14.08.2013
IT14.08.2013
MC14.08.2013
NL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
GR15.11.2013
PT16.12.2013
Former [2015/09]AT14.08.2013
BE14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
ES14.08.2013
FI14.08.2013
IT14.08.2013
MC14.08.2013
NL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
GR15.11.2013
PT16.12.2013
Former [2014/24]AT14.08.2013
BE14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
ES14.08.2013
FI14.08.2013
IT14.08.2013
NL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
GR15.11.2013
PT16.12.2013
Former [2014/23]AT14.08.2013
BE14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
FI14.08.2013
NL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
GR15.11.2013
PT16.12.2013
Former [2014/22]AT14.08.2013
BE14.08.2013
CY14.08.2013
DK14.08.2013
FI14.08.2013
NL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
GR15.11.2013
PT16.12.2013
Former [2014/21]AT14.08.2013
BE14.08.2013
CY14.08.2013
DK14.08.2013
FI14.08.2013
SE14.08.2013
SI14.08.2013
GR15.11.2013
PT16.12.2013
Former [2014/18]AT14.08.2013
BE14.08.2013
CY14.08.2013
FI14.08.2013
SE14.08.2013
SI14.08.2013
GR15.11.2013
PT16.12.2013
Former [2014/14]CY03.07.2013
AT14.08.2013
BE14.08.2013
FI14.08.2013
SE14.08.2013
SI14.08.2013
GR15.11.2013
PT16.12.2013
Former [2014/12]CY03.07.2013
AT14.08.2013
FI14.08.2013
SE14.08.2013
SI14.08.2013
GR15.11.2013
PT16.12.2013
Former [2014/11]CY03.07.2013
AT14.08.2013
FI14.08.2013
SE14.08.2013
PT16.12.2013
Former [2014/10]CY03.07.2013
AT14.08.2013
SE14.08.2013
PT16.12.2013
Former [2014/09]AT14.08.2013
SE14.08.2013
PT16.12.2013
Former [2014/08]PT16.12.2013
Documents cited:Search[E]WO2004002530  (ONO PHARMACEUTICAL CO [JP], et al) [E] 1-76 * page 2, paragraph 1 - page 3, paragraph 9 * * Formula (III); page 5, line 1 - line 37 * * Formulea III-J to III-M-1-3; page 13 - page 20 * * preparation examples 4-7(1); page 55 - page 58 ** claims 5-9 *
International search[X]WO0229001  (UNIV VIRGINIAN PATENT FOUNDATI [US], et al);
 [X]WO9512572  (ABBOTT LAB [US]);
 [X]EP0341081  (ONO PHARMACEUTICAL CO [JP]);
 [X]WO9312095  (PFIZER LTD [GB], et al);
 [X]JPS5690067  (HOKURIKU PHARMACEUTICAL);
 [X]WO02062798  (REDDY RESEARCH FOUNDATION [IN]);
 [X]WO9908501  (REDDY RESEARCH FOUNDATION [IN], et al);
 [X]JPH11158144  (SS PHARMACEUTICAL CO);
 [X]JPH10287634  (OTSUKA PHARMA CO LTD);
 [X]WO0200646  (SMITHKLINE BEECHAM CORP [GB], et al);
 [X]WO0100206  (DAIICHI SEIYAKU CO [JP], et al);
 [X]EP0573271  (LILLY CO ELI [US]);
 [X]EP0390215  (WAKUNAGA SEIYAKU KK [JP]);
 [A]WO02062389  (ONO PHARMACEUTICAL CO [JP], et al)
by applicantWO0160819
 GB112166
 US2868691
 US3095355
    - MOL PHARMACOL, (200012), vol. 58, no. 6, pages 1188 - 96
    - AM. J. PHYSIOL. LUNG CELL MOL. PHYSIOL., (2002), vol. 282, no. 1, page L91
    - CLIN. SCIENCE, (1999), vol. 96, page 431
    - J. CLIN. INVEST., (1998), vol. 101, page 1431
    - AM. J. PHYSIOL., (1994), vol. 267, no. 36, page C204
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.